Utilities Registry

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 11 - 20 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of autoimmune disease health state utilities (Chung MP et al., Rheumatology (Oxford). 2022. doi:10.1093/rheumatology/keab810)	2016 - 2020	SF-6D	United States of America	Calcinosis in systemic sclerosis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 12 participants from a prospective, single-arm, open-label, dose-escalation trial
Title Selection of orthopedic and musculoskeletal health state utilities (Nikou S, et al., J Exp Orthop. 2023. doi:10.1186/s40634-023-00568-1)	Year(s) of data collection 2016 - 2019	Valuation Method EQ-5D	Country Sweden	Condition Hip osteoarthritis
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics 12 individuals from the local hip arthroscopy registry
Title Selection of mental health health state utilities (Jain S et al., BMC Psychiatry. 2022. doi:10.1186/s12888-022-04165-x)	Year(s) of data collection 2017	Valuation Method EQ-5D, SF-6D	Country United States of America	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 39331 participants in the 2017 US National Health and Wellness Survey
Title Selection of general population health health state utilities (Park Y et al., Front Psychol. 2023. doi:10.3389/fpsyg.2023.1117369)	Year(s) of data collection 2017 - 2020	Valuation Method EQ-5D	Country Korea (Republic of)	Condition Chronic disease, General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 12395 participants (general population health) and 8341 participants (chronic disease) in the Korea National Health and Nutrition Examination Survey
Title Selection of general population health health state utilities (Teni FS et al., Qual Life Res. 2022. doi:10.1007/s11136-021-02982-3)	Year(s) of data collection 2017	Valuation Method EQ-5D-5L, TTO	Country Sweden	Condition General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 25867 participants from the population-based health survey Life & Health 2017, a cross-sectional self-administered postal survey in the regions/county councils in mid-Sweden
Title Selection of neurological disease health state utilities (Kalra S et al., Cureus. 2023. doi:10.7759/cureus.35045)	Year(s) of data collection 2017 - 2020	Valuation Method EQ-5D-3L	Country India	Condition Epilepsy
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 173 participants in a cohort study from a community-based randomized controlled trial to compare the QOL between people with epilepsy receiving home-based care (HBC) and routine clinic-based care (CBC)
Title Selection of neurological disease health state utilities (Gebrehiwet P et al., J Med Econ. 2023. doi:10.1080/13696998.2023.2192588)	Year(s) of data collection 2017 - 2019	Valuation Method EQ-5D-5L	Country Australia, Canada, Ireland, Netherlands, Spain, United States of America	Condition Amyotrophic lateral sclerosis
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 456 participants with clinical trial data from FORTITUDE-ALS that evaluated reldesemtiv versus placebo in patients with ALS
Title Selection of autoimmune disease health state utilities (Schreiber S et al., J Crohns Colitis. 2023. doi:10.1093/ecco-jcc/jjad018)	Year(s) of data collection 2017 - 2018	Valuation Method EQ-5D	Country Argentina, Australia, Belgium, Bulgaria, Canada, Croatia, Czechia, France, Georgia, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea (Republic of), Malaysia, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan (Province of China), Ukraine, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Ulcerative colitis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics An RCT for filgotinib in 786 adults with moderately to severely active UC
Title Selection of mental health health state utilities (Leijdesdorff SMJ et al., J Ment Health. 2023. doi:10.1080/09638237.2020.1836555)	Year(s) of data collection 2018 - 2019	Valuation Method EQ-5D-5L	Country Netherlands	Condition Mental Health
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 80 visitors of a Dutch multicenter organization for mental health support
Title Selection of oncology health state utilities (Chu YR et al., Integr Cancer Ther. 2023. doi:10.1177/15347354221150907)	Year(s) of data collection 2018 - 2019	Valuation Method EQ-5D	Country Taiwan (Province of China)	Condition Breast cancer
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics 450 breast cancer patients treated with and without adjunctive traditional Chinese medicine

← Previous results Next results →